Research Article
Long-Term Clinical Outcomes of Invasive Giant Prolactinomas after a Mean Ten-Year Followup
Table 3
Relations between PRL levels and clinicopathologic features in IGPs.
| Clinicopathologic parameters | PRL levels | value | Normal () | Hyperprolactinemia () |
| Age | | | 0.009 | Gender | | | 0.597 | Male | 15 | 3 | | Female | 5 | 2 | | Tumor volume before treatment | | | 0.33 | Final tumor volume | | | 0.562 | No remnant | 16 | 3 | | Remnant | 4 | 2 | | Tumor reduction percentage % | | | 0.275 | Cavernous sinus invasion | | | 0.645 | Bilateral | 11 | 2 | | Unilateral | 9 | 3 | | Duration of followup | | | 0.311 | Treatment strategy | | | 0.621 | BRC | 12 | 4 | | S + BRC | 8 | 1 | | Maximum BRC dose | | | 0.015 | Duration of maximum BRC dose | | | 0.074 |
|
|
S + BRC: surgery + bromocriptine.
|